PTPRK expression in intestinal organoids from patients with CeD and controls can modulate the phosphorylation of EGFR and ERK and proliferation [18] (Figure 2 and Figure 3 and Table 1). The gene discussed is EGFR; the disease is cranioectodermal dysplasia.